Arsenal Capital Partners Invests $449M in Certara
December 8, 2022
Arsenal Capital Partners closed a previously announced $449 million stock purchase in Certara, acquiring shares from funds controlled by EQT Private Equity and becoming a long-term minority investor. As part of the transaction Arsenal appointed Operating Partner David Spaight to Certara's board while Stephen McLean remains a director; Arsenal agreed to a two-year lock-up on the newly purchased shares.
- Buyers
- Arsenal Capital Partners
- Targets
- Certara, Inc.
- Sellers
- Funds controlled by EQT Private Equity
- Industry
- Biotechnology
- Location
- New Jersey, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Certara Acquires Pinnacle 21
October 4, 2021
Software
Certara, Inc. completed the acquisition of Pinnacle 21, a provider of SaaS solutions for clinical data standardization, validation and regulatory-submission readiness. Equity holders of Pinnacle 21 received approximately $250 million in cash and 2,239,717 restricted shares of Certara common stock; Certara said the deal expands its data-sciences and software capabilities and is expected to be accretive to revenue and adjusted EBITDA.
-
Arsenal Capital Partners Acquires Endpoint Clinical and Fortrea Patient Access from Fortrea
March 11, 2024
Healthcare Services
Arsenal Capital Partners has acquired Fortrea's Endpoint Clinical and Fortrea Patient Access businesses in a divestiture completed June 4, 2024. The sale allows Fortrea to sharpen its focus as a pure‑play CRO while Arsenal will position Endpoint and the Patient Access business for accelerated investment and growth under management led by Sam Osman.
-
PSG Equity Invests $80M Growth Round in CTERA
July 17, 2024
Cloud & SaaS
CTERA has raised $80 million in a primary and secondary growth investment from PSG Equity. The funding will support expansion of CTERA's hybrid cloud data platform and AI-driven data intelligence services; Ronen Nir of PSG has joined CTERA's board alongside existing investors Benchmark, Bessemer Venture Partners and Red Dot Capital Partners.
-
Certares and Knighthead Invest €300 Million in Avia Solutions Group
December 16, 2021
Aerospace & Defense
Avia Solutions Group has entered a strategic partnership with Certares Management LLC, with additional investment from Knighthead Capital Management, providing a €300 million investment. The capital will be used for strategic acquisitions, capital expenditures and general corporate purposes, and Certares will join the group's Board to support global expansion and capability growth.
-
Certara Acquires Applied BioMath
December 14, 2023
Biotechnology
Certara, Inc. has acquired Applied BioMath to expand its biosimulation capabilities and establish the life sciences industry's largest quantitative systems pharmacology (QSP) center of excellence. The acquisition combines Certara's biosimulation and AI portfolios with Applied BioMath's proprietary QSP platform and modeling expertise to industrialize QSP and accelerate drug development.
-
SK Capital Partners Acquires Majority Stake in Lacerta Group
January 11, 2021
Packaging
Funds advised by SK Capital Partners have acquired a majority interest in Lacerta Group, a Mansfield, Massachusetts-based manufacturer of thermoformed PET packaging solutions. The investment will support Lacerta's continued growth and scaling of its in-house manufacturing capabilities while founders Ali and Mory Lotfi retain a significant ownership stake.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.